gvtcx

Contract for supply of herpes zoster (shingles) vaccine(recombinant, adjuvanted)

Department of Health and Social Care (DHSC) Published 23 Apr 2021 Contracts Finder

key details

Statuscomplete
Category (CPV) 33651600
Deadline9 Sept 2020
Contract start1 Apr 2021
Contract end31 Mar 2025
Procedurelimited
SME suitableNo
OCIDocds-b5fd17-50d0ea97-ab72-4d47-8167-ebb6e110ba72

Awards (2)

This procurement was awarded to 2 suppliers. Values shown are per-award; the notice total is ·.

SupplierValueDateStatus
GlaxoSmithKline UK Ltd shared £66,131,483 16 Dec 2020 active
GlaxoSmithKline UK Ltd - Vaccines shared £66,131,483 16 Dec 2020 active

description

The provision of herpes zoster (shingles) vaccine(recombinant, adjuvanted) deliveries will be required from 1 April 2021 to 31 March 2023, with an option to extend for up to an additional 24 months.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
23 Apr 2021 Award (award) · 3147792b-bfc0-4626-b880-f2ce1ac32ae8-430851

more from Department of Health and Social Care (DHSC)

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.